Your browser doesn't support javascript.
loading
A risk score based on real-world data to predict early death in acute promyelocytic leukemia.
Österroos, Albin; Maia, Tânia; Eriksson, Anna; Jädersten, Martin; Lazarevic, Vladimir; Wennström, Lovisa; Antunovic, Petar; Cammenga, Jörg; Deneberg, Stefan; Lorenz, Fryderyk; Möllgård, Lars; Uggla, Bertil; Ölander, Emma; Aguiar, Eliana; Trigo, Fernanda; Höglund, Martin; Juliusson, Gunnar; Lehmann, Sören.
Afiliação
  • Österroos A; Department of Medical Sciences, Uppsala University, Uppsala.
  • Maia T; Department of Clinical Hematology, University Hospital Center of São João, Porto.
  • Eriksson A; Department of Medical Sciences, Uppsala University, Uppsala.
  • Jädersten M; Department of Hematology, Karolinska University Hospital, Stockholm.
  • Lazarevic V; Department of Hematology, Skåne University Hospital, Lund, Sweden; Stem Cell Center, Department of Hematology, Department of Laboratory Medicine, Lund University, Lund.
  • Wennström L; Department of Hematology, Sahlgrenska University Hospital, Gothenburg.
  • Antunovic P; Department of Hematology, Linköping University Hospital, Linköping.
  • Cammenga J; Department of Hematology, Linköping University Hospital, Linköping.
  • Deneberg S; Department of Hematology, Karolinska University Hospital, Stockholm.
  • Lorenz F; Department of Hematology, Norrland University Hospital, Umeå.
  • Möllgård L; Department of Hematology, Sahlgrenska University Hospital, Gothenburg.
  • Uggla B; Department of Medicine, Division of Hematology, Örebro University Hospital, Örebro.
  • Ölander E; Department of Hematology, Sundsvall Hospital, Sundsvall.
  • Aguiar E; Department of Clinical Hematology, University Hospital Center of São João, Porto.
  • Trigo F; Department of Clinical Hematology, University Hospital Center of São João, Porto.
  • Höglund M; Department of Medical Sciences, Uppsala University, Uppsala.
  • Juliusson G; Department of Hematology, Skåne University Hospital, Lund, Sweden; Stem Cell Center, Department of Hematology, Department of Laboratory Medicine, Lund University, Lund.
  • Lehmann S; Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Department of Hematology, Karolinska University Hospital, Stockholm. soren.lehmann@medsci.uu.se.
Haematologica ; 107(7): 1528-1537, 2022 07 01.
Article em En | MEDLINE | ID: mdl-35081688
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article